Jason Shafrin, Ph.D., Senior Managing Director, shares his insights in a recent podcast episode of Managed Care Cast, where he discusses his “Quantifying the Insurance Value for Rare Diseases: Duchenne Muscular Dystrophy” study published in the July 2024 issue of The American Journal of Managed Care. The study, with co-author, Suhail Thahir, Senior Consultant, estimates the insurance value of novel Duchenne muscular dystrophy (DMD) treatment from a survey of individuals planning to have children.
Key Contacts